Historical record - last NADAC publication: 1/1/2018
Product Information
CAVERJECT 20 MCG VIAL is a brand product labeled by Pharmacia & Upjohn Company LLC, priced at $95.7151 per EA under NDC 00009370105. Its NADAC has been published 269 times since Nov 28, 2013.
Strength
20.5 ug/mL
Manufacturer
Pharmacia & Upjohn Company LLCNDC
00009370105
Classification
Brand
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRACAVERNOUS
Last Updated
1/1/2018
Active Ingredients
ALPROSTADILApproval Type
New Drug (NDA)
FDA Application
NDA020379On Market Since
7/6/1995
Pharmacological Classes
Price Statistics
The NADAC for CAVERJECT 20 MCG VIAL has been published 269 times since Nov 28, 2013, and over the history we have for it it has risen 104.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $95.7151 per EA |
|---|---|
| All-time high | $95.7151 (Jan 16, 2019) |
| All-time low | $45.8480 (Dec 18, 2013) |
| Median price | $73.0217 |
| Average price | $71.6236 |
| Largest weekly change | +9.4% (Jun 7, 2017) |
| Weeks tracked | 269 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Alprostadil market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of CAVERJECT 20 MCG VIAL?
The current National Average Drug Acquisition Cost (NADAC) for CAVERJECT 20 MCG VIAL, manufactured by Pharmacia & Upjohn Company LLC, is $95.7151 per EA (NDC 00009370105), effective Jan 16, 2019.
How has the price of CAVERJECT 20 MCG VIAL changed over time?
Over the history we have for it, the NADAC for CAVERJECT 20 MCG VIAL has risen 104.1%. It has been tracked across 269 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CAVERJECT 20 MCG VIAL?
Since Nov 28, 2013, the NADAC for CAVERJECT 20 MCG VIAL has ranged from a low of $45.8480 (Dec 18, 2013) to a high of $95.7151 (Jan 16, 2019), with a median of $73.0217 per EA.
Are there cheaper alternatives to CAVERJECT 20 MCG VIAL?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of CAVERJECT 20 MCG VIAL, so no direct lower-cost alternative is listed.
Who manufactures CAVERJECT 20 MCG VIAL?
CAVERJECT 20 MCG VIAL (NDC 00009370105) is labeled by Pharmacia & Upjohn Company LLC, and CMS classifies it as a brand product.
Related Drugs
Same classification